scholarly journals Osmotic demyelination syndrome following slow correction of hyponatremia: Possible role of hypokalemia

2013 ◽  
Vol 17 (4) ◽  
pp. 231-233 ◽  
Author(s):  
Mohammed Ashraf ◽  
Parvaiz A. Koul ◽  
Umar Hafiz Khan ◽  
Rafi A. Jan ◽  
Sanaullah Shah ◽  
...  
2019 ◽  
Vol 20 (5) ◽  
pp. 1124 ◽  
Author(s):  
Charles Nicaise ◽  
Catherine Marneffe ◽  
Joanna Bouchat ◽  
Jacques Gilloteaux

Osmotic demyelination syndrome (ODS) is a disorder of the central myelin that is often associated with a precipitous rise of serum sodium. Remarkably, while the myelin and oligodendrocytes of specific brain areas degenerate during the disease, neighboring neurons and axons appear unspoiled, and neuroinflammation appears only once demyelination is well established. In addition to blood‒brain barrier breakdown and microglia activation, astrocyte death is among one of the earliest events during ODS pathology. This review will focus on various aspects of biochemical, molecular and cellular aspects of oligodendrocyte and astrocyte changes in ODS-susceptible brain regions, with an emphasis on the crosstalk between those two glial cells. Emerging evidence pointing to the initiating role of astrocytes in region-specific degeneration are discussed.


Cureus ◽  
2020 ◽  
Author(s):  
Tom D.Y. Reijnders ◽  
Wilbert M.T. Janssen ◽  
S.M. Laila Niamut ◽  
Andrea B Kramer

2014 ◽  
Vol 2014 ◽  
pp. 1-4 ◽  
Author(s):  
Ishan Malhotra ◽  
Shilpa Gopinath ◽  
Kalyana C. Janga ◽  
Sheldon Greenberg ◽  
Shree K. Sharma ◽  
...  

Hyponatremia is one of the most commonly encountered electrolyte abnormalities occurring in up to 22% of hospitalized patients. Hyponatremia usually reflects excess water retention relative to sodium rather than sodium deficiency. Volume status and serum osmolality are essential to determine etiology. Treatment depends on several factors, including the cause, overall volume status of the patient, severity of hyponatremic symptoms, and duration of hyponatremia at presentation. Vasopressin antagonists like tolvaptan seem promising for the treatment of euvolemic and hypervolemic hyponatremia in heart failure. Low sodium concentrations cause cerebral edema, but the overly rapid sodium correction can also lead to iatrogenic cerebral osmotic demyelination syndrome. Demyelination may occur days after sodium correction or initial neurologic recovery from hyponatremia. The following case report analyzes the role of vasopressin antagonists in the treatment of hyponatremia and the need for daily dosing of tolvaptan and the monitoring of serum sodium levels to avoid rapid overcorrection which can result in osmotic demyelination syndrome (ODS).


2021 ◽  
pp. 1-30
Author(s):  
Jacques Gilloteaux ◽  
Joanna Bouchat ◽  
Valery Bielarz ◽  
Jean-Pierre Brion ◽  
Charles Nicaise

Author(s):  
Miguel García-Grimshaw ◽  
Amado Jiménez-Ruiz ◽  
José Luis Ruiz-Sandoval ◽  
Carlos Cantú-Brito ◽  
Erwin Chiquete

Author(s):  
Tiziana Carandini ◽  
Mattia Pozzato ◽  
Elisa Scola ◽  
Sabrina Avignone ◽  
Anna M Pietroboni

2015 ◽  
Vol 22 (1) ◽  
Author(s):  
Omar Farooq ◽  
Pervaiz M. Zunga ◽  
Mohd I. Dar ◽  
Ishrat H. Dar ◽  
Samia Rashid ◽  
...  

2011 ◽  
Vol 22 (10) ◽  
pp. 1834-1845 ◽  
Author(s):  
Fabrice Gankam Kengne ◽  
Charles Nicaise ◽  
Alain Soupart ◽  
Alain Boom ◽  
Johan Schiettecatte ◽  
...  

2021 ◽  
Vol 69 (3) ◽  
pp. 777
Author(s):  
Sahil Mehta ◽  
AmithS Kumar ◽  
Darakshan Naheed ◽  
Neeraj Balaini ◽  
Vivek Lal

2014 ◽  
Vol 18 (9) ◽  
pp. 609-611 ◽  
Author(s):  
Atul Abhishek Jha ◽  
Vineet Behera ◽  
Anantharam Jairam ◽  
Krishna Venkatesh Baliga

Sign in / Sign up

Export Citation Format

Share Document